Vitiligo is a chronic autoimmune skin condition in which melanocytes - the cells responsible for producing skin pigment - are destroyed, resulting in clearly defined white or depigmented patches on the skin. It can affect any part of the body, including the face, hands, elbows, knees, and scalp.
Vitiligo is not contagious, not life-threatening, and not caused by poor hygiene. However, it can significantly impact self-esteem and quality of life, making specialist care essential.
The exact cause of vitiligo is multifactorial. Contributing factors include:
Led by Dr. Mithra Vasanth Vignesh, a qualified dermatologist with focused experience in pigmentation disorders.
No two cases of vitiligo are alike; every patient receives a customised protocol.
NB-UVB phototherapy, excimer laser, and surgical repigmentation under one roof.
We address not just the skin but the emotional and psychological impact of vitiligo.
Regular follow-up assessments to track repigmentation and adjust treatment as needed.
Tap a question to view the answer
There is currently no permanent cure for vitiligo, but significant repigmentation is achievable with the right treatment. Early intervention improves outcomes considerably. The goal of treatment is to stop further spread and restore as much natural skin colour as possible.
No. Vitiligo is not contagious in any way. It cannot be transmitted through touch, shared clothing, sexual contact, or proximity. Vitiligo is an autoimmune condition - it originates from within the body’s own immune system. You can confidently interact with, hug, or be in close contact with someone who has vitiligo without any risk of developing the condition.
Yes. Many vitiligo treatments are safe and effective for children, including topical calcineurin inhibitors, mild topical steroids, and NB-UVB phototherapy. NB-UVB is widely used in paediatric vitiligo and is considered safe with appropriate supervision. Surgical options are generally reserved for older adolescents with stable vitiligo.
Vitiligo can recur, particularly if the underlying autoimmune activity is not well controlled. Repigmentation achieved through phototherapy or surgery can be long-lasting, especially in stable vitiligo, but maintenance therapy and sun protection are important. Surgical repigmentation in stable vitiligo generally has a lower recurrence rate. Regular follow-up with your dermatologist helps detect early signs of relapse and allows prompt intervention to protect results.
Treatment timelines vary depending on the type of vitiligo, the area affected, and the treatment chosen. Topical therapies may show early results in 3 to 6 months. Phototherapy typically requires 3 to 6 months of regular sessions (2 to 3 times per week) before visible repigmentation appears. Surgical procedures for stable vitiligo often show results within 6 to 12 weeks post-procedure. Patience and consistency are key - vitiligo responds gradually, and close follow-up with your dermatologist ensures timely adjustments.
Currently Narrowband UVB (NB-UVB) phototherapy remains the gold standard for widespread vitiligo, with strong evidence for repigmentation across body areas. Excimer laser (308 nm) is highly effective for localised patches. For stable vitiligo, surgical options like suction blister grafting and melanocyte transplantation offer reliable and lasting repigmentation. The most effective approach is always personalised - based on vitiligo type, activity, body site, and patient age.
